Evidence map›Paper›PMID 35537728›Full record

ArticleSaudi medical journal2022

The effect of COVID-19 vaccine on ovarian reserve.

Çağanay Soysal, Elif Yılmaz

Open access · diamondAbstract read
In one paragraph

Article in Saudi medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. The Impact of Endometriosis on Ovarian Reserve: A Systematic Review.International journal of women's health · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Çağanay SoysalFrom the Department of Obstetrics and Gynecology, Dr. Sami Ulus Women's and Children's Health Teaching and Research Hospital, Ankara, Turkey.
Elif YılmazFrom the Department of Obstetrics and Gynecology, Dr. Sami Ulus Women's and Children's Health Teaching and Research Hospital, Ankara, Turkey.
Dr Sami Ulus Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo Evaluate the effect of messenger ribonucleic acid (mRNA) vaccines developed for the coronavirus disease-19 (COVID-19) on ovarian reserve.

methodsThis prospective cross sectional study was carried out between June and September 2021, in the Gynecology Polyclinics of a tertiary hospital, Ankara, Turkey, with 60 patients. Patients between the ages of 25-30 years old, who applied to the gynecology outpatient clinic and who were considering mRNA vaccination against severe acute respiratory syndrome coronavirus 2 were included in the study group, and those who did not plan to be vaccinated were included in the control group. Anti-müllerian hormone (AMH) was examined before vaccination (1-5 days before vaccination) and within 60-90 days after vaccination. In the unvaccinated group, AMH was examined once.

resultsThe mean age of the study group was 27.30±1.66 and of the control group was 27.40±1.69 (

conclusionIt is of great value that people who are planning pregnancy and who have hesitation regarding the effect of vaccines on ovarian reserve should be carefully informed that vaccines, which are one of the most important means of fighting against COVID-19 infection, have no effect on AMH levels. Prospective larger studies with a longer follow-up period are needed to confirm our results.

Indexed as

COVID-19Ovarian ReserveAdultAnti-Mullerian HormoneCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansPregnancyProspective StudiesRNA, MessengerAnti-Mullerian HormoneCOVID-19 VaccinesRNA, MessengerAMHCOVID-19mRNAovarian reservevaccine

Identifiers

PMID35537728
PMCPMC9280588
OpenAlexW4280618238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.